179 related articles for article (PubMed ID: 32559766)
1. Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition disease.
Bender S; Ayala MV; Bonaud A; Javaugue V; Carrion C; Oblet C; Rinsant A; Kaaki S; Oruc Z; Boyer F; Paquet A; Pons N; Hervé B; Ashi MO; Jaccard A; Delpy L; Touchard G; Cogné M; Bridoux F; Sirac C
Blood; 2020 Oct; 136(14):1645-1656. PubMed ID: 32559766
[TBL] [Abstract][Full Text] [Related]
2. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
[TBL] [Abstract][Full Text] [Related]
3. A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy.
Bonaud A; Bender S; Touchard G; Lacombe C; Srour N; Delpy L; Oblet C; Druilhe A; Quellard N; Javaugue V; Cogné M; Bridoux F; Sirac C
Blood; 2015 Aug; 126(6):757-65. PubMed ID: 26113545
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
[TBL] [Abstract][Full Text] [Related]
5. Animal Models of Light Chain Deposition Disease Provide a Better Understanding of Nodular Glomerulosclerosis.
Herrera GA; Turbat-Herrera EA; Teng J
Nephron; 2016; 132(2):119-36. PubMed ID: 26794829
[TBL] [Abstract][Full Text] [Related]
6. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
7. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
[TBL] [Abstract][Full Text] [Related]
8. Integrated expression of glomerular extracellular matrix proteins and beta 1 integrins in monoclonal light chain-related renal diseases.
Turbat-Herrera EA; Isaac J; Sanders PW; Truong LD; Herrera GA
Mod Pathol; 1997 May; 10(5):485-95. PubMed ID: 9160315
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
[TBL] [Abstract][Full Text] [Related]
10. Morphologic heterogeneity of renal light-chain deposition disease.
Gokden N; Barlogie B; Liapis H
Ultrastruct Pathol; 2008; 32(1):17-24. PubMed ID: 18300034
[TBL] [Abstract][Full Text] [Related]
11. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal immunoglobulin light and heavy chain deposition diseases: molecular models of common renal diseases.
Ronco P; Plaisier E; Aucouturier P
Contrib Nephrol; 2011; 169():221-231. PubMed ID: 21252522
[TBL] [Abstract][Full Text] [Related]
13. [Kidney involvement in light-chain deposition disease].
Merta M; Rysavá R; Zabka J; Stejskalová A; Vernerová Z; Haber J; Spicka I; Tesar V; Klener P
Sb Lek; 2002; 103(3):397-403. PubMed ID: 12688183
[TBL] [Abstract][Full Text] [Related]
14. Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.
Colombat M; Mal H; Copie-Bergman C; Diebold J; Damotte D; Callard P; Fournier M; Farcet JP; Stern M; Delfau-Larue MH
Blood; 2008 Sep; 112(5):2004-12. PubMed ID: 18483396
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
16. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
Buxbaum J; Gallo G
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1235-48. PubMed ID: 10626147
[TBL] [Abstract][Full Text] [Related]
17. Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy.
Kapur U; Barton K; Fresco R; Leehey DJ; Picken MM
Arch Pathol Lab Med; 2007 Sep; 131(9):1368-72. PubMed ID: 17824791
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications.
Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC
Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177
[TBL] [Abstract][Full Text] [Related]
19. Lenalidomide as a Beneficial Treatment Option for Renal Impairment Caused by Light Chain Deposition Disease.
Kimura S; Ohkawara H; Ogawa K; Tanaka M; Sano T; Harada-Shirado K; Takahashi H; Ueda K; Shichishima-Nakamura A; Matsumoto H; Ikeda K; Kazama JJ; Hashimoto Y; Ikezoe T
Intern Med; 2018 Dec; 57(24):3651-3657. PubMed ID: 30101913
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
